|
|||||
|
|
Effect of the glucagon-like peptide-1 receptor agonist liraglutide,compared to caloric restriction,on appetite,dietary intake,body fat distribution and cardiometabolic biomarkers: A randomized trial in adults with obesity and prediabetes |
|
| Authors: | Heidi J. Silver PhD Dianna Olson RD Dustin Mayfield RN Patricia Wright RN Hui Nian PhD Mona Mashayekhi MD John R. Koethe MD Kevin D. Niswender MD James M. Luther MD Nancy J. Brown MD |
| Affiliation: | 1. Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA;2. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA;3. Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA Department of Veteran Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee, USA;4. School of Medicine, Yale University, New Haven, Connecticut, USA |
| Abstract: | |
| Keywords: | caloric restriction diet glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide obesity prediabetes weight loss |